发明名称 Platelet-activating factor receptor antagonists
摘要 Cyclohexyl sulfonamide compounds which are platelet-activating factor (PAF) receptor antagonists. Said compounds may be useful, for example, for the treatment of atherosclerosis or other PAF-mediated disorders, including inflammatory, cardiovascular, and immune disorders.
申请公布号 US9029377(B2) 申请公布日期 2015.05.12
申请号 US201013382469 申请日期 2010.06.28
申请人 Merck Sharp & Dohme Corp. 发明人 Ogawa Anthony;Ujjainwalla Feroze;Chu Lin;Li Bing;Wei Lan;Xu Jinyou;Ok Hyun;Lackner Aaron;Kopka Ihor
分类号 A61K31/50;A61K31/4965;A61K31/505;A61K31/44;A61K31/4245;A61K31/4196;A61K31/42;C07D487/00;C07D401/00;C07D403/00;C07D231/02;C07D271/00;C07D261/02;C07D249/08;G01C23/00;G08G5/00 主分类号 A61K31/50
代理机构 代理人 Pecoraro Dianne;Fitch Catherin D.
主权项 1. A compound of formula I or a pharmaceutically acceptable salt thereof:wherein R1, and R2 are each independently selected from the group consisting of H, halogen, small alkyl, small alkoxy, small cycloalkyl, small haloalkyl, small haloalkoxy, or —OC1-C4alkyl, optionally substituted with fluoro; R3 is selected from the group consisting of substituted or unsubstituted mono- or polycyclic aryl or heteroaryl, H, halogen, amide, OCF3, small alkyl, small cycloalkyl, or small alkoxy; R4 and R5 are H, OH, or F, with the proviso that when R4 is OH, then R5 is H; and RA is selected from the group consisting of 3-pyridyl;wherein R6 and R7 are each independently selected from the group consisting of H, small alkyl, cycloalkyl, hydroxymethyl, and carboxymethyl and R8 is independently selected from N or CH;wherein R6 is H or small alkyl; andwherein R9 is H, F, small alkyl, OH or NH2.
地址 Rahway NJ US